All people
Rebecca Paul portrait

Researcher · Executive

Rebecca Paul

Isomorphic LabsVP, Head of Drug Design

Paul leads medicinal chemistry at Isomorphic Labs[1], connecting AI predictions with the laboratory craft of designing viable drugs. Her team turns structural insights from systems such as AlphaFold 3[2] into small molecules, balancing potency with safety and other properties needed for a medicine.

Career & education

Current role
2026-present
VP, Head of Drug Design
Previously
2022-2026
Team Leader -> Director
2019-2022
Senior Principal Scientist
Education

Work and education history is primarily focused on AI-relevant roles and may not be comprehensive.

References

  1. EFMC–ACSMEDI Medicinal Chemistry Frontiers — Rebecca Paulefmc-ismc.org

    The conference biography identifies Paul as Head of the Medicinal Drug Design Group at Isomorphic Labs.

  2. The rise of AlphaFold in drug designpubmed.ncbi.nlm.nih.gov

    Paul co-authored this review on applying AlphaFold to drug design.

About this profile

Based on public sources. If accuracy is important, verify details using the links or references.

For corrections, updates, or requests to remove information, contact us.

Reviewed August 10, 2026 · Checked for accuracy and new information.

Sharing card

Related people